AI Signal & Stock Analysis · Very Strong ↑
As of Oct 28 2026, 9:01 AM, AkshayaAI's signal for CAI is Very Strong ↑; the stock is at $35.98 (+6.85% today); overbought (RSI 72); technical trend is Raise; news sentiment is positive.
Data as of Oct 28 2026, 9:01 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal (Strength) | Very Strong ↑ |
|---|---|
| Price | $35.98 |
| Change today | +6.85% |
| RSI (14) | 72.21 |
| Relative volume | 0.91 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $10.2B |
| Forward P/E | 102.58 |
| 52-week high | 5.5% away |
| 52-week low | +153.3% above |
| Technical trend | RAISE-2026-10-14 |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 11/4/2026 4:30:00 PM |
As of Oct 28 2026, 9:01 AM, AkshayaAI assigns CAI (Caris Life Sciences Inc) a Very Strong signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
CAI's RSI is overbought (RSI 72). A reading above 70 is typically considered overbought and below 30 oversold.
CAI is trading about 6% below its 52-week high and 153% above its 52-week low as of Oct 28 2026, 9:01 AM.
CAI's next earnings date is 11/4/2026 4:30:00 PM.
CAI is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for CAI — not personalised investment advice. Always do your own research.
VRTX · REGN · ARGX · RVMD · ONC · RPRX
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Oct 28 2026, 9:01 AM and may not reflect real-time prices. Always do your own research. How these signals work →